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ABSTRACT 27 
In the pig, respiratory co-infections involving various pathogens are far more frequent than 28 
single infections. Amongst respiratory viruses, swine influenza type A virus (swIAV) and 29 
porcine reproductive and respiratory syndrome virus (PRRSV) are frequently associated. 30 
Previously, we performed co-infections with swIAV and PRRSV in porcine alveolar 31 
macrophages (PAM) and precision cut lung slices (PCLS). With these two approaches it was 32 
practically impossible to have co-infections of the same cells as the main target cell of swIAV 33 
is the epithelial cell while the main target of PRRSV is the PAM. This constraint makes the 34 
study of interference between the two viruses difficult at the cellular level. In the current 35 
report, an epithelial cell line expressing, CD163, the main receptor of PRRSV was generated. 36 
This cell line receptive for both viruses was used to assess the interference between the two 37 
viruses. Results showed that swIAV as well as PRRSV, even if they interacted differently 38 
with the modified epithelial cells, were clearly interfering with each other regarding their 39 
replication when they infected a same cell with consequences within the cellular antiviral 40 
response. Our modified cell line, receptive to both viruses, can be used as a tool to assess 41 
interference between swIAV and PRRSV in a same cell as it probably happens in the porcine 42 
host. 43 
 44 
INTRODUCTION 45 
In pigs, as in many species, respiratory co-infections are far more frequent than single 46 
infections (Choi et al., 2003; Fablet et al., 2012). Amongst viral co-infections, the association 47 
between swine influenza type A virus (swIAV) and porcine reproductive and respiratory 48 
syndrome virus (PRRSV) is frequent (Choi et al., 2003; Fablet et al., 2012). However, the 49 
assessment of the outcome of co-infections at molecular level is still very limited in the 50 
literature. Previously we assessed the impact of swIAV/PRRSV in vitro in alveolar 51 
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macrophages (Porcine Alveolar Macrophage, PAM) and ex vivo using precision cut lung 52 
slices (PCLS) (Dobrescu et al., 2014). Results showed that whereas a first infection of PCLS 53 
or PAMs by PRRSV did not affect the local H1N1 swIAV infection 3 h later, primary 54 
infection of PCLS or PAMs with swIAV partially inhibited their infection by the PRRSV 3 h 55 
later and some modifications in the host response. However, it was not possible to identify 56 
clearly co-infected cells in PCLS even if cells such as small populations of dendritic cells and 57 
in some circumstances type 1 pneumocytes can be targeted by both viruses. Moreover, there 58 
are still questions regarding full replication of swIAV in PAMs. These constraints make 59 
difficult the study of interference between the two viruses at the cellular level. To overcome 60 
that issue it was decided to generate a cell line susceptible to both viruses. Thus, newborn pig 61 
trachea (NPTr) cell line (Ferrari et al., 2003) was modified to express CD163, the main 62 
receptor of PRRSV (Calvert et al., 2007), allowing infection with both viruses. Using the cells 63 
we selected a protocol similar to the one used previously (Dobrescu et al., 2014), we 64 
evaluated the impact of one virus on the replication of the other, and we determined the 65 
consequences of co-infection at the host level by an assessment of the expression of various 66 
transcripts involved in viral recognition and resistance. Generated data were then compared to 67 
previous results obtained in a less constrained system based on PAMs and PCLS. 68 
 69 
MATERIALS AND METHODS 70 
NPTr cell line 71 
The newborn pig trachea epithelial cell line (NPTr) was kindly provided by Dr. M. Ferrari 72 
(Instituto Zooprofilattico Sperimental, Brescia, Italy) (Ferrari et al., 2003). The NPTr cell line 73 
was cultured in Minimum Essential Medium (MEM) (GIBCO®-BRL, ON, Canada) 74 
supplemented with 10% Fetal Bovine Serum (FBS) (Wisent Bioproducts, QC, Canada), 1 mM 75 
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sodium pyruvate, 10 I.U./mL of penicillin, 10 μg/mL of streptomycin and 250 g/L 76 
amphotericin B solution (Wisent Bioproducts) (Ferrari et al., 2003). 77 
 78 
Creation of PRRSV-permissive NPTr cells  79 
In order to modify the NPTr cell line to be permissive to PRRSV, a cDNA copy of the mRNA 80 
sequence of CD163, a known receptor of PRRSV (Calvert et al., 2007), was stably integrated 81 
to the genome. To do so, primary porcine alveolar macrophages (PAMs) were isolated from 82 
pathogen-free pig lungs (Provost et al., 2012). After RNA extraction with Trizol Reagent 83 
(Invitrogen™, New-Mexico, USA), a RT-PCR was performed using primers CD163-HindIII-84 
F (5’-AAGCTTAAGCTTATGGACAAACTCAGAATGGTGCTAC- 3’) and CD163-ClaI-85 
Reverse (5’- ATCGATATCGATTCATTGTACTTCAGAGTGGTCTCCTGAGGGATTTAG 86 
-3’) with SuperScript® One-Step RT-PCR for long template (Invitrogen), the full mRNA 87 
sequence of CD163 was expected at approximately 3623 bp (Genbank: DQ067278.1). The 88 
resulting product was digested by HindIII and ClaI restriction enzymes (New England 89 
Biolabs, Ipswich, MA, USA) and inserted into the retroviral plasmid pLNCX2 (Clontech 90 
Laboratories Inc., California, USA). The integrated sequence was analysed to accurately 91 
match the cDNA sequence of CD163 (Genbank DQ067278). To stably integrate the coding 92 
sequence of CD163, the protocol from a retroviral transduction kit, the Retro-X System® 93 
(Clontech Laboratories Inc.) was followed. Briefly, the CD163 cDNA was introduced in the 94 
pLNCX2 plasmid. The pLNCV2-CD163 plasmid was then co-transduced with pVSV-G®, 95 
coding for mammalian retrovirus envelop proteins, in provided Eco-Pack® GP2-293 cells 96 
(Clontech Laboratories Inc.). This enabled the production of non-replicating mammalian cell 97 
specific retrovirus containing the pLNCX2-CD163 plasmid. NPTr cells were then infected 98 
with the supernatant of the GP2-293 cells for 8 hours (h), left for 12 h with fresh medium, 99 
then re-infected with the same retrovirus for 8 h. Cells were then cultured in G418 (Sigma-100 
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Aldrich, Missouri, USA) for clone selection. CD163 integration was determined by PCR and 101 
transcription by RT-PCR, as described below, and expression of the protein was assessed by 102 
IFA with mouse monoclonal anti-pig CD163 antibody (AbD Serotec, Oxford, UK), as 103 
previously described (Provost et al., 2012). 104 
 105 
Detection of CD163 mRNA by RT-PCR  106 
The extraction of total RNA was done by Trizol® reagent (Invitrogen). A reverse-107 
transcription was performed following protocol of QuantiTech Rev. Transcription kit 108 
(Qiagen™, Missisauga, ON, Canada). To facilitate detection, a new reverse primer was 109 
designed: CD163-detect-R (5’-CCAGAGAAACTGACAGCACTTCCACATTCA- 3’) to be 110 
used with the forward primer CD163-HindIII-F, as described above. 111 
 112 
Sequence analyses 113 
The nucleotide sequencing of CD163 gene was performed by the Diagnostic Laboratory of the 114 
Faculté de médicine vétérinaire of Université de Montréal and the gene analysis was done 115 
using the Geneious bioinformatics version 5.4.6 (Biomatters, Ltd., Auckland, New Zealand). 116 
 117 
Cells and viruses 118 
For influenza virus propagation, Madin-Darby Canine Kidney (MDCK, ATCC CCL-34) and 119 
NPTr cells were cultured while for PRRSV propagation MARC-145 monkey cells (ATCC 120 
CRL-12231) were used. These cells were cultured as previously described (Delgado-Ortega et 121 
al., 2014b; Dobrescu et al., 2014). PAM cells were obtained from lungs of 2 to 14 week-old 122 
pigs as previously explained (Lévesque et al., 2014). To collect the PAM cells, animals were 123 
humanely sacrificed following the ethic protocol 12-Rech-1640. This protocol was approved 124 
by Université de Montréal ethic committee, which is following the guidelines of the Canadian 125 
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Council of Animal Care. The swine influenza strain A/Sw/Saskatchewan/18789/02 126 
(swIAV/Sk02) of H1N1 subtype was isolated from pigs in Saskatchewan in 2002 (Karasin et 127 
al., 2004). The titer of influenza virus was determined on MDCK and NPTr cells by a plaque 128 
assay, as described previously (Shin et al., 2007). Stock of the virus reached titer of 9.5 × 107 129 
plaque forming units (pfu)/mL after purification. The virulent PRRSV strain ISU-12-SAH 130 
was obtained from ATCC (ATCC VR-2385, Hanassas, VA, USA) and the quantitation of 131 
PRRSV was performed in MARC-145 cells. The titer (4.8 x 106) was calculated and 132 
expressed as TCID50/mL (Reed and Muench, 1938). 133 
Series of six wells of CD163 expressing NPTr cells (NPTr-CD163) (2 x 105 cells/well) in a 134 
24-well plate were single-infected or co-infected with swIAV and PRRSV at a MOI of 5. 135 
Additionally 6 non-infected wells were used as controls. Virus attachment was allowed for 1 h 136 
at 4°C. Cells were then incubated at 37°C. One hour after the temperature shift, the cells were 137 
washed twice with phosphate buffered saline (PBS) and maintained at 37°C in 1 mL of MEM 138 
(GIBCO®-BRL) supplemented with 10% FBS and 1% antibiotic/antimycotic (Anti-Anti 100x, 139 
GIBCO®-BRL). Fifteen and eighteen hours after the temperature shift the culture medium was 140 
removed, clarified twice by centrifugation (1,000 x g), divided into aliquots, and stored at -141 
80°C. For superinfections, six wells of NPTr-CD163 cells (2 x 105 cells/well) were first 142 
infected with swIAV (MOI of 5), then superinfected with PRRSV (MOI of 5) 3 h later. In 143 
parallel, six wells of NPTr-CD163 cells were infected with PRRSV (MOI of 5) and 144 
superinfected with swIAV (MOI of 5) 3 h after infection with PRRSV. The 3 h delay between 145 
infections was selected based on previous studies where interference between the same 146 
viruses or others was intensively assessed in vitro and in vivo (Dobrescu et al., 2014; Meurens 147 
et al., 2004b; Schynts et al., 2003). After the first infection, virus attachment was allowed for 148 
1 h at 4°C. Cells were then further incubated at 37°C and superinfections were performed 3 h 149 
after the temperature shift. One hour after the temperature shift and 1 h after each 150 
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superinfection cells were washed twice with PBS and further incubated at 37°C in 1 mL of 151 
MEM (GIBCO®-BRL) supplemented with 10% FBS and 1% antibiotic/antimycotic (Anti-152 
Anti 100x, GIBCO®-BRL). Additionally 8 non-infected wells were used as controls. Fifteen 153 
hours post-superinfection, the culture medium was removed, clarified twice by centrifugation 154 
(1,000 x g) and stored at -80°C. 155 
 156 
Gene expression analysis using quantitative real-time polymerizing chain reaction 157 
Real-time PCR Primers (targeting M protein gene of swIAV, Open Reading Frame 7 (ORF7) 158 
of PRRSV, DAI, LGP2, MDA5, RIG1, TLR3, TLR8, IFNα, IFNβ, IFNλ1, IL6, CCL20, 159 
MX2, OAS, and PKR transcripts) were designed and optimized using Clone Manager 9 160 
(Scientific & Educational Software, Cary, NC, USA) and were purchased from Invitrogen 161 
(Carlsbad, CA, USA) as previously described (Table 1) (Dobrescu et al., 2014). NPTr-CD163 162 
cells were suspended in Trizol reagent (Invitrogen) with ceramic beads (BioSpec Products, 163 
OK, USA) and total RNA was isolated using RNeasy Plus Mini Kit (Qiagen). The absence of 164 
genomic DNA contamination was verified using prepared RNA as a template for quantitative 165 
real-time PCR (qPCR). RNA concentration was determined by measuring optical density at 166 
260nm (OD260) and the RNA quality was assessed by calculating OD260/OD280 ratio and 167 
by capillary electrophoresis (Agilent 2100 Bioanalyzer, Agilent Technologies Inc., Santa-168 
Clara, USA). cDNA was generated from 100-200 ng of RNA per reaction and RT-PCR was 169 
performed using the SuperScript™ III Platinum® Two-Step RT-qPCR Kit as per the 170 
manufacturer’s recommendations (Invitrogen). The generated cDNA was stored at −80 ºC. 171 
qPCR assays were carried out as previously described using the three most stable reference 172 
genes (Delgado-Ortega et al., 2014a; Dobrescu et al., 2014). qPCR data were expressed as 173 
relative values after Genex macro analysis (Bio-Rad) (Vandesompele et al., 2002) using the 174 
Cycle quantification (Cq) from the samples for the different transcripts. 175 
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 176 
Statistical analysis 177 
Data for the comparison of differences in relative mRNA expression between cells and tissues 178 
were expressed as relative values. All statistical analyses were done using computer software 179 
Prism 6 for Windows (version 6.02; GraphPad Software, San Diego, CA, USA). One-Way 180 
ANOVA was used to detect differences among the groups. To account for the non-normal 181 
distribution of the data, all data were sorted by rank status prior to ANOVA statistical 182 
analysis. Tukey’s test was used to compare the means of the ranks among the groups. P values 183 
less than 0.05 were considered significant. 184 
 185 
RESULTS-DISCUSSION 186 
Creation of a new model to study PRRSV and influenza co-infections in vitro 187 
To study PRRSV and swIAV co-infection, NPTr cells have been genetically modified to 188 
express the protein CD163, which is one of PRRSV’s principal cell receptor (Calvert et al., 189 
2007; Das et al., 2010). Many other papers have shown that expression of CD163 protein 190 
enabled PRRSV permissivity to cells (Lee et al., 2010; Lee and Lee, 2010; Patton et al., 2009; 191 
Van Gorp et al., 2010). NPTr cell line did not show any CD163 mRNA production by RT-192 
PCR (Figure 1A). As such, CD163 cDNA was isolated from PAMs and cloned into the NPTr 193 
cell line using a retroviral transduction kit. To verify the stable introduction of the CD163 194 
cDNA into the new genetically modified NPTr cells genome (NPTr-CD163 cells) and the 195 
expression of the protein, a RT-PCR and a specific porcine anti-CD163 immunofluorescence 196 
assay (IFA) was performed (Figure 1). RT-PCR detection revealed the presence of CD163 197 
mRNA in NPTr-CD163, as compared to non-modified NPTr cells (negative control) and 198 
primary PAMs (positive control) (Figure 1A). IFA by porcine anti-CD163 confirms high 199 
expression of the protein (Figure 1C). Furthermore, the permissiveness of the modified NPTr-200 
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CD163 cells to PRRSV type II Quebec reference strain (IAF-Klop) was evaluated by IFA 201 
with polyclonal pig anti-PRRSV serum (data not shown).  202 
 203 
PRRSV and swIAV single and co-infections of NPTr-CD163 cells 204 
NPTr-CD163 cells were then single or co-infected with PRRSV and swIAV for a maximum 205 
of 18 h (Figure 2). Co-infections were carried out simultaneously or with a 3 h delay between 206 
the two viruses.  207 
The replication of both viruses was assessed by RT-qPCR at the end of the experiment. We 208 
observed that PRRSV impacted the replication of swIAV especially when the cells were 209 
simultaneously co-infected and when PRRSV virus was added to the cells 3 h after swIAV 210 
(P<0.05) (Figure 2). On the contrary co-infections with PRRSV added to the cells 3 h before 211 
swIAV did not show any impact on swIAV replication. Regarding PRRSV replication it could 212 
be observed that PRRSV replication was clearly decreased when swIAV infected NPTr-213 
CD163 cells 3 h before PRRSV (Figure 2). Thus, when these data were compared to previous 214 
ones where PAMs and PCLS were similarly single and co-infected with the same viruses a 215 
difference was identified (Dobrescu et al., 2014). Indeed, in cells permissive to both viruses 216 
PRRSV could interfere with swIAV replication which was not the case in co-infections of 217 
PAMs or PCLS (Dobrescu et al., 2014). Interference between viruses was clearly observed in 218 
NPTr-CD163 cells. Since both viruses are RNA viruses mobilizing similarly cellular 219 
machinery and defenses this strong interference was expected and here confirmed. Variations 220 
in the impact of interference on the replication of the second virus could be explained, for 221 
instance, by differences in penetration kinetics between viruses as previously observed with 222 
other enveloped viruses (Meurens et al., 2004a). 223 
Regarding the antiviral response of the NPTr-CD163 cells and the potential impact of co-224 
infection on it, several observations could be made. First, in line with previous data (Dobrescu 225 
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et al., 2014), our strain of PRRSV – ISU-12-SAH – was a very poor inducer of the cellular 226 
antiviral response as observed with the low expression of several transcripts related to its 227 
response (Figure 3) confirming previous observations with PAMs and PCLS (Dobrescu et al., 228 
2014). On the contrary the strain of swIAV (A/Sw/Saskatchewan/18789/02) was clearly 229 
triggering the expression of various transcripts (see LGP2, TLR8, IFN types 1 and 3 in Figure 230 
3), especially IFNλ1 mRNA. However, it did not seem to have consequences on the interferon 231 
stimulated genes (ISGs) we assessed. IFN type 3 mRNA were more expressed than IFN type 232 
1 mRNA suggesting a particular role for these IFNs in epithelial cells. This observation 233 
confirms previous results showing a preferential expression of IFN type 3 in primary airway 234 
epithelial cells (Ioannidis et al., 2013) and clear expression of IFNλ1 mRNA in NPTr cells 235 
and PCLS in response to an European strain of H3N2 swIAV (Delgado-Ortega et al., 2014b). 236 
When PRRSV was added to the cells on the same time or after swIAV, transcript levels of 237 
expression were similar or decreased (see for instance IFNλ1, Figure 3). PRRSV effect was 238 
less obvious when the virus was infecting the cells before swIAV. For ISGs, even if both 239 
viruses were poor inducer after 18 h of stimulation, it appears that transcript levels of 240 
expression were very low in the experimental conditions involving a PRRSV infection before 241 
or after swIAV infection (Figure 3). Globally, the two viruses were also interfering with each 242 
other at the cellular level, usually with one decreasing the induction triggered by the other, 243 
probably as a consequence of their altered replications. However, neither synergistic nor 244 
additive effects were observed at the cellular level when the two viruses were simultaneously 245 
infecting NPTr-CD163 cells. Additive and synergistic effects between PRRSV and swIAV 246 
were reported previously (Dobrescu et al., 2014) but it was not in a single pure cell population 247 
like here, but in tissue slice where various cell types were present and could communicate 248 
through cytokines network. Thus, it seems that at the cellular level, early in the infection 249 
process, both viruses are mostly interfering. While at tissue level, even if there is still 250 
11 
 
interference there is also the establishment of synergistic and additive effects when the host 251 
response is considered. 252 
In the current report interactions between two strains of PRRSV and swIAV were assessed 253 
early in co-infections of a same genetically modified target epithelial cell line expressing the 254 
PRSSV receptor, CD163. Results using this new tool showed that both RNA viruses can 255 
clearly interfere with each other when infecting the same cell with consequences on the 256 
antiviral cell response. Further researches are needed to assess the impact of this observed 257 
interference later in the infection process and on the protein production that cannot be 258 
assessed at early times. Moreover, interactions between various cells types exposed to both 259 
viruses would undoubtedly need further assessment too. Finally, additional in vivo and field 260 
experiments taking advantages of the recent developments in porcine immuno-microbiology 261 
and the new tools available should be performed to clarify complex relations between micro-262 
organisms in the respiratory tract and the lung. 263 
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 354 
FIGURE CAPTIONS 355 
Figure 1: NPTr-CD163 cells express the CD163 protein  356 
NPTr cells were infected with a CD163-coding retrovirus, selected, cloned and tested for 357 
expression of the protein CD163. RT-PCR detection of mRNA of partial CD163 in NPTr, 358 
NPTr-CD163, and PAMs (A). Immunofluorescence against CD163 protein in NPTr (B) and 359 
modified NPTr-CD163 (C) cells. White scale bar represent 200 µm. 360 
 361 
Figure 2: Viral replication - Relative viral expression (ORF7-PRRSV and M protein-swIAV 362 
genes) after 15 h or 18 h of infection of NPTr-CD163 cells. For every situations n=6 + median 363 
except control where n=8 + median. Dot plots within each graph with no common 364 
superscripts are significantly different (P < 0.05). 365 
 366 
Figure 3: Viral recognition (LGP2, MDA5, and TLR8), Interferons (IFNα, IFNβ, and 367 
IFNλ1), and Response to Interferons (MX2, OAS, and PKR) - Relative expression of 368 
transcripts after 15 h or 18 h of infection of NPTr-CD163 cells. For every situations n=6 + 369 
median except control where n=8 + median. Dot plots within each graph with no common 370 
superscripts are significantly different (P < 0.05).  371 
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